AsianScientist (May 15, 2012) – Bristol-Myers Squibb Company and Tsinghua University of Beijing, China, announced on Monday the formation of a multi-year research partnership.
Under the agreement, Bristol-Myers Squibb will fund research efforts at Tsinghua University’s School of Life Sciences to identify and validate novel targets in oncology and immunology.
“This is Bristol-Myers Squibb’s first discovery collaboration in China and is an example of the company’s deepening commitment to the country,” said Francis Cuss, M.D., senior vice president, Research, Bristol-Myers Squibb.
The collaboration will also focus on structural biology research, the science of mapping the 3D protein structure of biological molecular targets that could serve as the basis for future drug discovery projects.
“On April 22, 1911, almost 101 years ago, Tsinghua University was founded. We have committed ourselves to working with the finest institutions and enterprises to jointly conduct cutting-edge research. In that spirit, Tsinghua University’s School of Life Sciences is building a strategic partnership with Bristol-Myers Squibb,” said Professor Kejun Kang, vice president of Tsinghua University.
Source: Bristol-Myers Squibb.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.